Skip to main content
WVU Morgantown’s new, phased return to campus delays the start of classes to August 26. Visit the Return to Campus website for the latest.

COVID-19 Funding Opportunities

Below is a list of research-funding databases, portals, and opportunities specifically related to COVID-19. Not all of these opportunities are necessarily an ideal match for Eberly College faculty specifically, but this is intended as a wide-ranging resource for the university community as a whole. Please keep checking back as we will update this list frequently!

Index
Funding Portals and Search Engines
West Virginia Resources
Federal Opportunities
Private Foundations, Corporations and Other Agencies
Additional Resources and Databases

Funding Portals and Search Engines

Pivot at West Virginia University
Pivot focuses on what matters most to you—the ability to identify and connect with funding opportunities and other researchers, locally and globally. It combines the most comprehensive, editorially-maintained database of funding opportunities worth an estimated $33 billion with a unique database of 3 million scholar profiles—and growing. Access to Pivot is limited to authenticated users only; you must have an email address that ends in one of the following ways:  mail.wvu.edu, mix.wvu.edu, or hsc.wvu.edu. To stay updated on COVID-19 funding information, we recommend saving a “COVID-19” search. Results will be emailed to you weekly.
https://pivot.proquest.com

Grant Station
Current funding opportunities for nonprofits in the area of COVID-19, updated each business day and listed by deadline date. Use Ctrl + F on your keyboard to search funding opportunities or jump to a particular section of interest by using the links directly:
https://grantstation.com/covid19fundingsopps

Johns Hopkins University COVID-19 Funding Opportunities
The JHU Office of the Vice Provost for Research (VPR) has compiled several funding opportunities specific to COVID-19. This list will be updated as new opportunities arise.
https://hub.jhu.edu/novel-coronavirus-information/research-preparedness/research-preparedness-covid-19-funding-opportunities/

InfoEd Global COVID-19/Coronavirus Resources
InfoEd Global is proud to be able to share this library of COVID-19 funding opportunities and resources with our colleagues in the research realm and the broader community at large.
https://www.infoedglobal.com/COVID19/COVID-19

COSSA Compiling Social Science Resources Related to COVID-19
COSSA (Consortium of Social Science Associations) is compiling a list of resources for social scientists and stakeholders related to the COVID-19 pandemic. The list includes guidance from federal science agencies, collections of publicly available peer-reviewed research related to the crisis, resources from COSSA member associations, and more. There are a number of new databases for researchers wishing to amplify their work that may have relevance to the current crisis, including the COVID-19 Open Research Dataset, supported by the Allen Institute for AI, and a grassroots effort on GitHub to compile new social science research related to COVID-19.
https://www.cossa.org/resources/covid-19/

USDA COVID-19 Federal Rural Resource Guide

The COVID-19 Federal Rural Resource Guide is a helpful resource published by the U.S. Department of Agriculture unveiled by the USDA for rural communities looking for federal funding and partnership opportunities to help address COVID-19. This resource matrix organizes funding opportunities identified in the CARES Act and other federal resources that can help support rural America. Opportunities are categorized by customer and assistance type.
https://www.rd.usda.gov/sites/default/files/USDA_COVID-19_Fed_Rural_Resource_Guide.pdf 

West Virginia Resources

West Virginia COVID-19 Information Portal
This resources includes state grants, available funding sources, links to federal grants and grant application guidelines. 
https://grants.wv.gov/en 

WV Humanities Council CARES Act Emergency Relief Fund
The West Virginia Humanities Council announces its CARES Act Emergency Relief Grant, designed to assist nonprofit humanities-centered institutions and organizations in West Virginia by providing general operating and/or programming support during this period of financial hardship caused by the current COVID-19 pandemic. Applicants must serve the general public, must be able to show current direct loss of income, loss of opportunity, or increased financial hardship in direct connection to the COVID-19 pandemic, and must be able to demonstrate an emergency need and ability to use a timely infusion of grant funds to maintain organizational operations.  Beginning early May, applications will be accepted on a rolling basis until the funds are completely committed through October 10, 2020.
http://wvhumanities.org/cares-act/

COVID-19 Business Relief Resources
In order to aid businesses and communities dealing with the impact of COVID-19, the West Virginia Department of Commerce has developed a directory of human and financial resources. Please continue to receive public health information from the Department of Health and Human Resources and Governor Jim Justice’s official website. Below you will find important information about resources from both state and federal agencies available to businesses and communities affected economically from COVID-19.
https://westvirginia.gov/covid19/

Philanthropy West Virginia COVID-19 Relief Funds
Philanthropy West Virginia has created a list of emergency relief funds from West Virginia’s Community Foundations, United Way agencies and other local organizations. These organizations are accepting donations, and providing relief to West Virginia nonprofit organizations communities affected by the pandemic.
http://www.philanthropywv.org/covid-19-relief-funds/

YCF Emergency Impact Grants in Response to COVID-19  
In response to the ongoing COVID-19 pandemic, our Board of Directors has established the YCF Emergency Impact Fund. Targeted to assist nonprofit organizations in the five-county region served by YCF (Harrison, Marion, Monongalia, Preston, and Taylor Counties), the new fund will provide grant funding to nonprofits addressing the most critical needs in our communities. Grants must be used for unanticipated, additional expenses related to COVID-19.  Currently, we invite those organizations providing human services to apply. Awards of up to $2,500 will be made on a rolling basis. Funding priorities are emergency food, shelter, and other basic needs for the most vulnerable members of our community.
http://www.ycfwv.org/grant-opportunities/
Applications accepted on a rolling basis. 

Federal Opportunities

Index
National Institute of Health
National Science Foundation
Department of Defense
Other Federal Opportunities 

NATIONAL INSTITUTE OF HEALTH 

NIH Funding Opportunities Specific to COVID-19
This new page contains a listing of active and expired funding opportunities specific to Coronavirus Disease 2019 (COVID-19).
https://grants.nih.gov/grants/guide/COVID-Related.cfm

Funding for NEW NIH-funded Projects

Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) aims to support research to strengthen the healthcare response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and future public health emergencies, including pandemics. While research related to the direct clinical effects of COVID-19 are supported by other funding opportunities, the purpose of this funding opportunity is to focus on the role and impact of digital health interventions [e.g., mobile health (mhealth), telemedicine and telehealth, health information technology (IT), and wearable devices] to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions for secondary effects (e.g., behavioral health or self-management of chronic conditions) that are utilized during and following the pandemic, particularly in populations who experience health disparities and vulnerable populations.
https://grants.nih.gov/grants/guide/pa-files/PAR-20-243.html
Deadline(s): August 20, 2020, December 2, 2020, March 2, 2021

Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) 
The purpose of this Funding Opportunity Announcement (FOA) is to support basic and clinical mechanistic research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) susceptibility, routes of infection, course of disease, morbidity and mortality in people with pre-existing diseases, or adverse acute or chronic outcomes in organs, tissues, and biological systems of specific interest to NIDDK. These include diabetes and other metabolic diseases, obesity, and endocrine, digestive, liver, pancreas, kidney, urological, and hematologic tissues and diseases.
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-20-021.html
Deadline: December 16, 2020

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project
NIH is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) in individuals with Down syndrome in conjunction with the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project. Because many people with Down syndrome are at increased risk of having co-occurring medical conditions, such as pulmonary disease, cardiac problems, obesity, diabetes, sleep apnea, and altered immune function that may predispose them to more severe infection with SARS-CoV-2, they may be particularly vulnerable to COVID-19 complications. Combined with shared living situations, and reduced access to testing and treatment services due to disparities in provision of resources, the impact of COVID-19 infection in people with Down syndrome is likely to be elevated. The overarching goal of this NOSI is to improve understanding and treatment of COVID-19 infection in individuals with Down syndrome and reduce COVID-19 associated morbidity and mortality for this population, which may be disproportionately affected by, have higher infection rates of, and/or be at elevated risk for adverse outcomes from contracting the virus. Applications for this initiative must be submitted electronically using one of the following target opportunities or their subsequent reissued equivalents: PA-18-591 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) or PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/notice-files/not-od-20-129.html
Deadlines: November 12, 2020, March 12, 2021, and July 12, 2021

NIH Director’s Emergency Transformative Research Awards (R01 Clinical Trial Optional)
This FOA solicits applications responsive only to the COVID-19 public health emergency through support of the CARES Act. All other Transformative Research Award applications must be submitted in response to RFA-RM-20-013. The NIH Directors Transformative Research Award Program supports individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original, and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the nations research workforce. Individuals from diverse backgrounds and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply to this Funding Opportunity Announcement. No preliminary data are required. Projects must clearly demonstrate, based on the strength of the logic, a compelling potential to produce a major impact on SARS-CoV-2 prevention, preparation, or response. The NIH Directors Transformative Research Award is a component of the High-Risk, High-Reward Research (HRHR) Program of the NIH Common Fund. Due to the COVID-19 public health emergency, the Common Fund will dedicate funds provided by the CARES Act to support a total of 5-10 Transformative Research Awards (through this FOA) or Early Independence Awards (through RFA-RM-20-021) that bring new, innovative perspectives and approaches to the prevention of, preparation for, or response to coronavirus SARS-CoV-2, domestically or internationally. Any relevant area of coronavirus SARS-CoV-2 research is welcome, including behavioral/social science research, research on health disparities, novel therapeutics, and other related topics. As with all High-Risk, High-Reward Research program applications, innovation may be technological or conceptual. 
https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-20-020.html
Deadline: September 30, 2020

Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional)
NIH is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19). This emergency cooperative agreement funding opportunity announcement (FOA) from the National Institutes of Health (NIH) provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) initiative, a consortium of community-engaged research projects to understand factors that have led to disproportionate burden of the pandemic on the underserved and/or vulnerable populations so that interventions can be implemented to decrease these disparities. This FOA seeks to fund a single Coordination and Data Collection Center (CDCC) as an integral part of the consortium. The funding for this supplement is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020. The CDCC will serve as a national resource, working with NIH scientific staff and consortium members to coordinate and facilitate research activities. The CDCC will also serve as a spoke in the larger NIH initiatives by providing deidentified individual data to an NIH-based data center. The RADx-UP CDCC will provide overarching support and guidance in the following four domains: (1) Administrative Operations and Logistics, (2) COVID-19 Testing Technology, (3) Community and Health System Engagement and (4) Data Collection, Integration and Sharing. The CDCC will facilitate RADx-UP collaborative research by providing organizational and analytical infrastructure and expertise, supporting data integration and analysis, and coordinating across RADx-UP projects and the NIH-supported RADx initiatives that are developing and validating new COVID-19 testing technologies.
https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-013.html
Deadline: August 7, 2020

NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required)
This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated multi-site clinical trials (all phases or stages) of interventions focused on specific aging-related issues to reducing transmission, risk, morbidity, mortality, severity, or complications of Coronavirus Disease 2019 (COVID-19).
https://grants.nih.gov/grants/guide/pa-files/PAR-20-234.html
Deadline(s): September 1, 2020; October 1, 2020; November 2, 2020; December 1, 2020; January 4, 2021; and February 1, 2021.

Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) encourages applications to implement and evaluate community interventions testing 1) the impacts of mitigation strategies to prevent COVID-19 transmission in NIH-designated health disparity populations and other vulnerable groups; and 2) already implemented, new, or adapted interventions to address the adverse psychosocial, behavioral, and socioeconomic consequences of the pandemic on the health of these groups.
https://grants.nih.gov/grants/guide/pa-files/PAR-20-237.html
Deadlines: August 28, 2020; December 1, 2020

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)      
The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19). 
https://grants.nih.gov/grants/guide/pa-files/PAR-20-177.html  
Deadline: Applications will be accepted on a rolling basis, beginning on April 30, 2020

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)      
The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19).  
https://grants.nih.gov/grants/guide/pa-files/PAR-20-178.html
Deadline: Applications will be accepted on a rolling basis, beginning on April 30, 2020

NIH Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed)   
The purpose of this Funding Opportunity Announcement (FOA) is to support the use of Collaborative Cross (CC) mouse lines to advance understanding of the host genetics involved in immune regulation and function and to further develop CC mouse lines that more faithfully reproduce human immune responses. Applicants may include CC, CC derivatives with reproducible genomes and/or CC-RIX mice to accomplish these goals. Research areas supported by this FOA include immune system development, function or regulation; mechanisms governing immune response to infectious pathogens, vaccines or adjuvants; host susceptibility factors and mechanisms of pathogen-induced immunopathology; and immune mechanisms involved in the development and progression of immune-mediated diseases, such as allergy/asthma, autoimmunity, primary immunodeficiency, inflammation, and cell/organ/tissue transplant rejection or tolerance.   
https://grants.nih.gov/grants/guide/pa-files/PAR-18-781.html   
Deadline: September 9, 2020

NIH Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)  
NIAID is issuing this Notice of Special Interest (NOSI) to highlight the need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19. NIAID is therefore encouraging applications to address research objectives described in the link below. Applications in response to this NOSI must be submitted using the following targeted funding opportunity: PA-20-135; Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional), which is intended to provide funds for NIH grantees applying to expand the scope of their active grant.  
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-031.html  
Deadline: Rolling , through April 5, 2021

NIH Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)
NIEHS considers the COVID-19 pandemic to be an unpredictable event that provides a limited window of opportunity to collect human biological samples or environmental exposure data (e.g measuring levels of pollutants in air or water during a long period of social distancing due to COVID-19). If you are applying for a new R21 grant that does not build off of an existing NIEHS grant, the NIEHS recommends applying through this funding opportunity announcement (FOA) that is intended to support novel environmental health research in which an unpredictable event or policy change provides a limited window of opportunity to collect human biological samples or environmental exposure data. The primary motivation of the FOA is to understand the consequences of natural and human-made disasters, emerging environmental public health threats, and policy changes in the U.S. and abroad. A distinguishing feature of an appropriate study is the need for rapid review and funding, substantially shorter than the typical NIH grant review/award cycle, for the research question to be addressed and swiftly implemented. The shortened timeframe will be achieved by more frequent application due dates and expediting peer review, council concurrence and award issuance. The entire cycle, from submission to award, is expected to be within 3-4 months.
https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-19-011.html
Deadline(s): Applications are accepted on a rolling basis through October 3, 2022

NIH Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01 Clinical Trial Optional)
The purpose of this Funding Opportunity Announcement (FOA) is to support investigative and collaborative research focused on understanding the long-term effects of natural and/or human-made disasters on health care systems serving health disparity populations in communities in the U.S., including the U.S. territories. NIH-designated health disparity populations include racial and ethnic minorities (Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asians, Native Hawaiians and other Pacific Islanders), sexual and gender minorities, socioeconomically disadvantaged populations, and underserved rural populations.
https://grants.nih.gov/grants/guide/PA-files/PA-20-172.html
Deadline:  Standard dates apply

AHRQ Notice of Intent: Revision Supplements to Existing AHRQ Grants and Cooperative Agreements to Address Health System Responsiveness to COVID-19   
AHRQ intends to publish a new funding notice allowing requests for urgent revision supplements to existing AHRQ grants and cooperative agreements to address health system responsiveness to COVID-19. AHRQ intends to allow grantees with active AHRQ research grants to submit requests for competitive revision supplements to address timely health system and healthcare professional response to COVID-19. Grant activity codes to be included or excluded from the funding notice will specified in the announcement. It is expected that competitive revision supplement requests will capitalize on the expertise of grant personnel and the institutional environment to expand the specific aims of the on-going research to develop high-impact new knowledge concerning COVID-19. Competitive revision supplements will be limited in duration (perhaps 12 months). The amount of supplemental funds that may be requested will be limited, and will be specified in the funding notice. AHRQ expects to make at least $2.5M available to fund meritorious revision supplements in FY2020. AHRQ plans to release the supplement announcement in April 2020 with an opening date in mid-May. Please also see AHRQ’s Notice of Intent to publish a new FOA requesting new competitive applications targeting the evaluation of health system responsiveness to COVID-19.   
https://grants.nih.gov/grants/guide/notice-files/NOT-HS-20-007.html   
Deadline: TBD

Administrative Supplements and Competitive Revisions for EXISTING NIH-Funded Projects

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project
NIH is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) in individuals withDown syndrome in conjunction with the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project. Because many people with Down syndrome are at increased risk of having co-occurring medical conditions, such as pulmonary disease, cardiac problems, obesity, diabetes, sleep apnea, and altered immune function that may predispose them to more severe infection with SARS-CoV-2, they may be particularly vulnerable to COVID-19 complications. Combined with shared living situations, and reduced access to testing and treatment services due to disparities in provision of resources, the impact of COVID-19 infection in people with Down syndrome is likely to be elevated. The overarching goal of this NOSI is to improve understanding and treatment of COVID-19 infection in individuals with Down syndrome and reduce COVID-19 associated morbidity and mortality for this population, which may be disproportionately affected by, have higher infection rates of, and/or be at elevated risk for adverse outcomes from contracting the virus.
Applications for this initiative must be submitted electronically using one of the following target opportunities or their subsequent reissued equivalents:

  • PA-18-591   Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
  • PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-129.html
Deadlines: November 12, 2020, March 12, 2021, and July 12, 2021

Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
This Notice of Special Interest (NOSI) highlights the urgent need to understand and address COVID-19 morbidity and mortality disparities among underserved and vulnerable populations across the United States. These two-year community-engaged Testing Research Projects will examine SARS-CoV-2 infection patterns and efforts to increase access and effectiveness of diagnostic methods through the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative. The overarching goal is to understand factors that have led to disproportionate burden of the pandemic on these underserved populations so that interventions can be implemented to decrease these disparities. The funding for this supplement program is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020. The Office of the Director (OD) is therefore offering Emergency Competitive Revisions to active eligible grants and cooperative agreements addressing the objectives described below. This NOSI is one of four related RADx-UP funding opportunities. This Testing Research Projects NOSI will support supplements to NIH grantees that are part of large-scale networks, consortia, centers and other current programs that have adequate capacity, infrastructure, and established community-engaged relationships to support large-scale testing. Applications in response to this NOSI must be submitted using the following targeted funding opportunity or its subsequent reissued equivalents: PA-20-135 Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) is intended to provide funds for NIH grantees applying to expand the scope of their active grant.
Deadline: August 7, 2020

Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
This Notice of Special Interest (NOSI) highlights the urgent need to understand and address COVID-19 morbidity and mortality disparities among underserved and vulnerable populations across the United States. These two-year community-engaged Testing Research Projects will examine SARS-CoV-2 infection patterns and efforts to increase access and effectiveness of diagnostic methods through the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative. The overarching goal is to understand factors that have led to disproportionate burden of the pandemic on these underserved populations so that interventions can be implemented to decrease these disparities. The funding for this supplement program is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020. Applications in response to this NOSI must be submitted using the following targeted funding opportunity or its subsequent reissued equivalents: PA-20-135 Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) is intended to provide funds for NIH grantees applying to expand the scope of their active grant.
Deadlines: August 7, 2020; September 8, 2020

Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
This Notice of Special Interest (NOSI) highlights the urgent need to understand the social, ethical, and behavioral implications (SEBI) of COVID-19 testing among underserved and/or vulnerable populations across the United States through the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative. The overarching goal is to understand factors that have led to disproportionate burden of the pandemic on these underserved populations so that interventions can be implemented to decrease these disparities. The funding for this supplement is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020. The Office of the Director is therefore offering Emergency Competitive Revisions to active eligible grants and cooperative agreements addressing the objectives described below. This NOSI is one of four related RADx-UP opportunities. The purpose of this SEBI NOSI is to identify, analyze, and address the social, ethical, and behavioral factors likely to influence access and uptake of COVID-19 testing in underserved and/or vulnerable populations. Single or mixed methods approaches involving community partners will inform the development and evaluation of such testing programs. These studies will assess the ethical, historical, healthcare, social and contextual factors surrounding COVID-19 testing, as well as how cultural beliefs and attitudes, perceived expectations, and preferences influence the ability and willingness to get tested and participate in follow-up evaluations. Findings will be used to develop interventions to mitigate barriers to access and increase uptake of testing. Studies focused on unintended consequences of COVID-19 testing in these groups are also of interest when related to social and ethical issues. Applications in response to this NOSI must be submitted using the Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) mechanism (PA-20-135) or its subsequent reissued equivalents.
Deadlines:  August 7, 2020; September 8, 2020

Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19
This Notice of Special Interest (NOSI) highlights interest in research to strengthen the healthcare response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and to future public health emergencies, including pandemics. While the direct clinical effects of COVID-19 are supported by other funding opportunities, the purpose of this NOSI is to support research to address secondary health effects of the social, behavioral, and economic changes, particularly among populations who experience  health disparities and vulnerable populations through the use of digital health assessments and interventions to yield measurable near-term impact. Applications are expected to describe how research outcomes will lead to a tangible difference within 6 months to a year of completing the supplement work, with respect to improving how we identify, treat, or provide services for health conditions secondary to the COVID-19 pandemic for health disparate and vulnerable populations. Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent: PA-18-591 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) or PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement -Clinical Trial Optional).
Deadline: Applications will be accepted on a rolling basis until December 15, 2020

Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations
The COVID-19 pandemic and its associated mitigation strategies are expected to have significant psychosocial, behavioral, and socioeconomic impacts on health, which are exacerbated in populations that experience health disparities and other vulnerable groups, leading to disproportionately adverse consequences. Those experiencing health disparities prior to the COVID-19 pandemic are at increased risk of infection and other COVID-19 related consequences (e.g., job loss, unpaid leave, lost wages). Research is needed to test community interventions focused on the prevention (or slowing) of COVID-19 transmission, evaluate local and state policies and programs intended to mitigate COVID-19 exposure and improve adherence, and reduce the negative impact of the multifaceted consequences on the health of populations who experience health disparities and other vulnerable groups. This work may include leveraging and scaling existing resources (e.g., health education materials, technology, social media, mass media, social support networks, social services). In domains and populations in which the evidence base is limited, the development, testing, and implementation of novel or adapted interventions to address the negative health consequences of the COVID-19 pandemic (including the unintended health consequences of population-level interventions) may also be needed to address the unique needs of populations. Applications in response to this NOSI must be submitted using one of the following target opportunities or subsequent reissued equivalent: PA-18-591, Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) is intended to provide funds for NIH grantees where the work proposed in the supplement is within the scope of the ongoing grant or PA-18-935, Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional) is intended to provide funds for NIH grantees applying to expand the scope of their active grant.  https://grants.nih.gov/grants/guide/notice-files/NOT-MD-20-022.html
Deadline: Applications will be accepted on a rolling basis until December 15, 2020

Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders
Coronavirus Disease 2019 (COVID-19) is a recently emerged human disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). There is a paucity of data on the impact of SARS-CoV-2 on the sensory and communicative functions within the scientific mission areas of NIDCD. NIDCD invites applications for research on COVID-19 in relation to NIDCD’s scientific programs of hearing, balance, taste, smell, voice, speech and language (HBTSVSL). Given the early stage of COVID-19 research, it is critical that there is a strong premise for research proposals submitted in response to this NOSI. When appropriate, NIDCD encourages multi-disciplinary approaches to move the research beyond in vitro and animal models. See the guidelines for a list funding opportunity announcements (FOAs) that may be used to submit applications under this NOSI.
Deadline: This notice applies to due dates on or after October 5, 2020 and subsequent receipt dates through September 8, 2022 

NOSI: Availability of Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19)
The National Center for Complementary and Integrative Health (NCCIH) calls for research on the therapeutic and/or mechanistic effects on SARS-CoV-2/COVID-19 of natural product–based complementary remedies including, but not limited to: herbal therapies, vitamins, supplements, probiotics, microbial therapies, and Chinese medicine herbal preparations.
Deadline: August 17, 2020

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials  
NHLBI is issuing this Notice of Special Interest (NOSI) due to the urgent need for early phase clinical trials to evaluate new or existing interventions that may prevent or treat Coronavirus Disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  NHLBI seeks to leverage existing clinical trials expertise and, using  NHLBI programs that are actively conducting Phase I-III clinical trials, to rapidly initiate and conduct Phase I-Phase I/II (bridging) clinical trials in patients at risk for SARS-CoV-2 infection and/or patients with COVID-19. It is strongly recommended that the parent activity code be one of the following:  P01R01R33R41R42R43R44, U01U24U54UH3, or  UM1. Topics of specific interest to the NHLBI include the safety and efficacy of interventions for primary prevention and/or treatment of COVID-19, associated clinical phenotypes, and surrogate outcomes, relevant to heart, lung, and blood (HLB) diseases. Programs currently conducting research without an active Phase I-III clinical trial may wish to consider applications to  NOT-HL-20-757. Applicants responding to this NOSI must have appropriate capabilities, infrastructure, and attributes. These key components are expected to ensure qualified personnel and site capabilities for the safe conduct of Phase I-Phase I/II (bridging) for COVID-19.
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-20-782.html 
Deadline: Applications will be accepted on a rolling basis through October 5, 2020

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System  
NINDS is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and on biological effects on the nervous system of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Research of interest must fall within NINDS’s scientific mission, which is to support basic, translational, and clinical neuroscience research to expand fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease. In order to rapidly improve our understanding of the neurological consequences of infection of SARS-CoV-2 and of COVID-19, NINDS is encouraging the submission of applications for supplements to address the biology, pathophysiology, prevention, diagnosis, sequelae, or treatment of the 2019 Novel Coronovirus that are directly related to the NINDS mission. Applications for this initiative must be submitted using one of the following opportunity announcements or the subsequent reissued equivalent.  PA-18-591 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) or  PA-18-935 - Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional). Applications for research that fall within the scope of an existing NINDS award should be submitted through  PA-18-591 (Parent Admin Supp Clinical Trial Optional). Eligible activity codes fare limited to the mechanisms listed in  PA-18-591
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-20-051.html
Deadline: Applications will be accepted on a rolling basis until April 14, 2021

Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) 
Coronaviruses are a diverse family of viruses that cause a range of disease in humans and animals, and there are currently no approved coronavirus vaccines or therapeutics. In January 2020, a novel coronavirus, 2019-nCoV, was identified as the causative agent of an outbreak of viral pneumonia centered around Wuhan, China. Current information regarding confirmed cases is changing daily and can be found on the  Centers for Disease Control and Prevention website and through other sources such as the  NIH website. Transmission characteristics and the associated morbidity and mortality are not completely understood, but there is clear evidence of human-to-human transmission. Many other aspects of viral pathogenesis, natural history, and host range are poorly understood. Given this, there is an urgent public health need to better understand the 2019-nCoV, particularly to improve prevention of disease transmission among older adults and mitigation of disease severity and mortality in older adults with COVID-19. In order to rapidly improve our understanding and available control measures for 2019-nCoV, NIA is encouraging the submission of applications for either Administrative Supplements ( PA-18-591) or Competitive Revisions ( PA-18-935) to active grants to address the research areas outlined on the site below.  Participating Institutes include NIA, NIMH, and NIAAA.  
https://grants.nih.gov/grants/guide/notice-files/NOT-AG-20-022.html 
Deadline: Applications will be accepted on a  rolling basis through May 1, 2021 

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus 
National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the COVID-19. NCATS is especially interested in research in the use of microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection, and advance the translation of research findings into diagnostics, therapeutics, and vaccines.A multi-organ on chip approach is strongly encouraged though not required. Please document access to a BSL-3 facility or include scientific justification for use of alternative facilities, for example using an engineered a COVID-19 pseudovirus that expresses the key surface Spike protein, which mediates its entry into cells. This Notice announces the availability of administrative supplements for investigators and institutions funded through: The NIH Microphysiological Systems (MPS) Program; or SBIR/STTR-supported investigators, provided the award involves tissue chips; or Microphysiological systems programs from across NIH. Applications for this initiative must be submitted using  PA-18-591 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) 
https://grants.nih.gov/grants/guide/notice-files/NOT-TR-20-016.html
Deadline: Applications will be accepted on a rolling basis through January 25, 2022  

NIH Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus 
NIDA is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 Novel Coronavirus (2019-nCoV, also known as COVID-19). NIDA is especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders. Applications in response to this NOSI must be submitted using the targeted funding opportunities in the link below. 
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-20-047.html 
Deadline: Rolling through March 31, 2021

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for accelerating the development, translation, and commercialization of technologies to address Coronavirus Disease 2019 (COVID-19). The NIBIB is seeking applications from current grantees to develop life-saving technologies that can be ready for commercialization within one to two years. Applications in response to this NOSI must be submitted using one of the following target opportunities or subsequently reissued equivalents:
  • PA-20-135   Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional), which is intended to provide funds for NIH grantees applying to expand the scope of their active grant.  
  • PA-18-591  - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional), which is intended to provide additional funds for NIH grantees for work that falls within the scope of their active grant.  

https://grants.nih.gov/grants/guide/notice-files/NOT-EB-20-008.html  
Deadline: Applications will be accepted on a rolling basis through November 10, 2020

NIH Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) 
NIAID is issuing this Notice of Special Interest (NOSI) to highlight the need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19. NIAID is therefore offering Competitive Revisions to active NIAID grants addressing research objectives at the link below. 
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-034.html 
Deadline: Rolling, through March 25, 2021  

Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA  
The impact of the COVID-19 pandemic on the nation is vast, especially on health and well-being. Research suggests that alcohol consumption tends to increase during times of duress and uncertainty such as disasters and other traumatic events, and as such alcohol is often misused to cope with stress, anxiety, and other uncomfortable emotions. In addition, the misuse of alcohol to cope with the stress as a result of physical distancing and other policy measures, and a lack of access to supportive social networks and treatment for people with pre-existing alcohol use disorder (AUD) are significant concerns during the pandemic. These outcomes are particularly challenging with respect to COVID-19 because alcohol misuse can interfere with normal immune system function and elevate susceptibility to viral infections of the respiratory system. Alcohol-associated damage to the liver, heart, and other organs may also complicate health outcomes in individuals with COVID-19. This NOSI encourages applications, in the form of urgent competitive revisions and administrative supplements to existing grants and cooperative agreements, to assess the impact of alcohol as a biological contributor to COVID-19 outcomes, to assess behavioral, social, and economic consequences of the pandemic and to assess the responses that the pandemic has provoked as they relate to alcohol consumption and related outcomes. NIAAA is encouraging research in the following areas, including those that capitalize on existing research cohorts, to investigate urgent research questions of significance to the COVID-19 pandemic within the general population and among underserved populations, such as racial, ethnic and gender minorities, individuals with low socioeconomic status, and those who are incarcerated or homeless. Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent. PA-18-591 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)  PA-18-935 - Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional) is intended to provide funds for NIH grantees applying to expand the scope of their active grant.
Deadline: Applications will be accepted on a rolling basis through April 15, 2021

Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
NIEHS is issuing this Notice of Special Interest (NOSI) to address the urgent need for mission-relevant research to understand the impact of environmental exposures on Coronavirus Disease 2019 (COVID-19) and its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). NIEHS is particularly interested in applications that will provide insight into the role of environmental exposures in pathogenicity, transmission, individual susceptibility, or prevention and intervention strategies. NIEHS seeks to promote rapid understanding of the potential contributions of current and past exposure to environmental agents that may exacerbate COVID-19 susceptibility, disease severity, and progression. Examples of environmental exposures relevant to the NIEHS mission include: toxic chemicals, air pollutants, second hand tobacco smoke, e-cigarette vapors, metals, and other environmental chemical exposures that may impact health outcomes. In addition, some health outcomes that are linked to environmental exposures (asthma, diabetes, and other pulmonary, cardiovascular, and metabolic diseases) are also risk factors for COVID-19. NIEHS is accepting applications addressing COVID-19 through the urgent competitive revision, and time-sensitive mechanisms. To better understand the role of environmental exposures in SARS-Cov-2 transmission and COVID-19 disease incidence and progression, NIEHS encourages applications to be submitted using the following opportunities: 
  • PA-20-135 Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional), which is intended to provide funds for NIH grantees applying to expand the scope of their active grant.
Deadlines: August 3, 2020; September 1, 2020; October 1, 2020; November 2, 2020; December 1, 2020; January 4, 2021; February 1, 2021; March 1, 2021; April 1, 2021; May 3, 2021  

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus 
NIMH is issuing this Notice of Special Interest (NOSI) to highlight interest in research to strengthen the mental health response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and to future public health emergencies, including pandemics. NIMH is especially interested in research to provide an evidence base for how a disrupted workforce may adequately respond/adapt to and maintain services or provide additional care for new or increasing mental health needs, as well as to learn about the effects of the virus and public health measures to prevent spread of COVID-19 that may have an impact on mental health. Research addressing the intersection of COVID-19, mental health, and HIV treatment and prevention are also of interest to NIMH. Applications in response to this NOSI must be submitted using the following targeted funding opportunities or their subsequent reissued equivalents:PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional) is intended to provide funds for NIH grantees applying to expand the scope of their active grant. PA-18-591 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) is intended to provide funds for NIH grantees where the work proposed in the supplement is fully within the scope of the ongoing grant. 
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-20-047.html 
Deadline: Rolling, through April 15, 2021

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences 
This Notice of Special Interest (NOSI) highlights the urgent need for social, behavioral, economic, health communication, and epidemiologic research relevant to the 2019 Novel Coronavirus (SARS-CoV-2) and COVID-19. This NOSI encourages urgent competitive supplements and administrative supplements to existing longitudinal studies that address key social and behavioral questions related to the COVID-19 pandemic, including adherence to and transmission mitigation from various containment and mitigation efforts; social, behavioral, and economic impacts from these containment and mitigation efforts; and downstream health impacts resulting from these social, behavioral, and economic impacts,including differences in risk and resiliency based on gender, race and ethnicity, socioeconomic status, and other social determinants of health. Applications in response to this NOSI must be submitted using the following targeted funding opportunities or subsequent re-issued equivalents:  PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional) is intended to provide funds for NIH grantees applying to  expand the scope of their active grant.  PA-18-591 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) is intended to provide funds for NIH grantees where the work proposed in the supplement is fully within the scope of the ongoing grant. Participating institutes and centers include the OBSSR, NHLBI, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI, NICHD, and NINR.  
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-097.html 
Deadline: Rolling, through March 31, 2021

Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities 
This NOSI is soliciting research in health disparity populations that -seeks to understand: 1) how state and local policies and initiatives mitigate or exacerbate disparities in health services use and health outcomes; 2) the role that community-level protective and resilience factors and interventions have in mitigating the effects of the sector disruptions that the COVID-19 outbreak causes; and 3) how behavioral and/or biological mechanisms may contribute to COVID-19 manifestations. Outcomes of interest include, but are not limited to, the COVID-19 incidence, prevalence, and mortality rates in defined populations; substance abuse and mental health effects; impact on chronic conditions; effects on severe maternal morbidity and mortality; and influence on access, utilization, and quality of health care (including needed medical care, medical treatments, and access to prescription drugs) Projects must include a focus on one or more NIH-designated populations that experience health disparities in the United States, which include racial and ethnic minority groups (Blacks or African Americans, Hispanics or Latinos, American Indians and Alaska Natives, Asian Americans, Native Hawaiians and other Pacific Islanders), less privileged socioeconomic status, sexual and gender minorities and underserved rural populations. Applications in response to this NOSI must be submitted using one of the following target opportunities or subsequent reissued equivalent.  PA-18-591 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) is intended to provide funds for NIH grantees where the work proposed in the supplement is within the scope of the ongoing grant.  PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional) is intended to provide funds for NIH grantees applying to expand the scope of their active grant.  Participating Institutes include NIMHD, NIA and NIMH. 
https://grants.nih.gov/grants/guide/notice-files/NOT-MD-20-019.html 
Deadline: Rolling, through May 1, 2021

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR
National Institute of Dental and Craniofacial Research (NIDCR) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19). NIDCR will place a high priority on topics that would be of immediate and high impact to protect and ensure the safety of personnel and patients in dental practices. These topics include prevention of SARS-COV-2 transmission and improvements in the detection and diagnosis of COVID-19; as well as acquisition of a more robust understanding of SARS-CoV-2 pathogenesis. Further, topics addressing influence and interaction of sex (a biological variable) and gender (a social construct), race and ethnicity, and those addressing questions about risk, prevention, and health outcomes are also of interest.
https://grants.nih.gov/grants/guide/notice-files/not-de-20-022.html
Deadline: November 2, 2020

Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations
Projects may evaluate existing or ongoing community-based programs or policies (i.e., natural experiments), or prospectively test new or adapted interventions. Multilevel interventions that do not solely target individuals, but also address the upstream determinants that influence individual functioning and health outcomes are strongly encouraged. Projects should be designed to test hypotheses about mechanisms of action that account for an intervention’s effects; mechanisms may operate at any level of analysis. Key questions include: To what extent do existing interventions slow the spread of COVID-19 in specific populations and geographic hotspots? To what extent do policies, guidelines, and other interventions facilitate adherence and mitigate the multifaceted impacts of COVID-19 on health in populations that experience health disparities and vulnerable groups? Can established models of crisis and disaster response and management be applied to address the needs of health disparity and other vulnerable populations?
Topics:
-Mitigation strategies in populations who experience health disparities and other vulnerable groups.
-Evaluating community interventions (existing, new, or adapted) to ameliorate the negative health impacts of the COVID-19 pandemic in populations with health disparities and other vulnerable populations.
https://grants.nih.gov/grants/guide/notice-files/not-md-20-022.html
Deadline: Rolling through December 15, 2020

Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19
This Notice of Special Interest (NOSI) highlights interest in research to strengthen the healthcare response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and to future public health emergencies, including pandemics. While the direct clinical effects of COVID-19 are supported by other funding opportunities, the purpose of this NOSI is to support research to address secondary health effects of the social, behavioral, and economic changes, particularly among populations who experience health disparities and vulnerable populations through the use of digital health assessments and interventions to yield measurable near-term impact.
Topics:
-Strategies to increase the reach, access, engagement, efficiency, quality and sustainability of existing evidence-based or validated digital health interventions to address healthcare needs of health disparate and other vulnerable populations, including screening, prevention, self-management, wellness behaviors and treatment both during and following the pandemic.
-Studies to evaluate the near-term impact of replacement (or substitution) of face to face services with digital health as a result of the pandemic to address health disparities and vulnerable population needs.
https://grants.nih.gov/grants/guide/notice-files/not-mh-20-053.html
Deadline: Rolling through December 15, 2020 

Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
NIAID is issuing this Notice of Special Interest (NOSI) to highlight very specific and limited needs for Competitive Revision applications to active NIAID grants in order to further build the infrastructure that NIAID needs to support the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) research response. This NOSI replaces NOT-AI-20-034 which was rescinded with this issuance of this Notice. NIAID is allowing the submission of applications for Competitive Revisions to active grants to increase and enhance select research efforts to facilitate the Federal SARS-CoV-2/COVID-19 research response. Areas of interest are limited to: Support to BSL3 facilities actively engaged in the SARS-CoV-2/COVID-19 research response, e.g., equipment sharing arrangements. Applications proposing new construction, alterations and renovations for planned and active BSL3 facilities are not responsive to this NOSI; Generation of critical reagents to support the SARS-CoV-2/COVID-19 research response; Expansion of relevant data systems to expeditiously share SARS-CoV-2/COVID-19 research resources with the broad research community; and Expansion of clinical trial infrastructure, or site preparation, for urgent SARS-CoV-2/COVID-19 clinical trial activities. Applications proposing clinical trials are not responsive to this NOSI. Investigators interested in responding to this NOSI are strongly encouraged to contact the program officers listed below to discuss the proposed project in the context of the parent award and the limited and specific NIAID needs identified above.
Applications in response to this NOSI must be submitted using the following targeted funding opportunity or subsequently reissued equivalent: PA-20-135; Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional), which is intended to provide funds for NIH grantees applying to expand the scope of their active grant.
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-059.html
Deadline: July 2, 2021

Notice of Special Interest (NOSI): National Cancer Institute (NCI) Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-19)
Through this Notice of Special Interest (NOSI), the National Cancer Institute (NCI) announces an opportunity for current NCI funded Principal Investigators whose postdoctoral fellows have temporarily lost stipend support from a non-profit funder because of the COVID-19 global pandemic may apply for an administrative supplement to cover the postdoctoral fellow's salary plus applicable F&A for the time and effort devoted to the NCI funded grant. Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent. PA-18-591- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional).
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-082.html
Deadline: August 15, 2020

NATIONAL SCIENCE FOUNDATION

NSF Dear Colleague Letter on the Coronavirus 
The NSF encourages investigators to use existing NSF funding mechanisms to submit proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge. 
https://www.nsf.gov/pubs/2020/nsf20052/nsf20052.jsp?org=NSF 
Deadline: rolling

NSF Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) 
The Office of Advanced Cyberinfrastructure (OAC) within the Directorate for Computer and Information Science and Engineering is inviting RAPID proposals and supplemental funding requests to existing awards that address COVID-19 challenges through data and/or software infrastructure development activities. 
https://www.nsf.gov/pubs/2020/nsf20055/nsf20055.jsp?WT.mc_id=USNSF_80 
Deadline: rolling

NSF Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19 
NSF is seeking Phase I SBIR/STTR proposals focused on the development and deployment of new technologies, products, processes, and services with the potential to positively impact the nation’s and world’s ability to respond to the COVID-19 crisis. The Division of Innovation and Industrial Partnerships (IIP) of the Engineering Directorate invites US-based small businesses to submit Phase I proposals focused on the development and deployment of new technologies, products, processes, and services with the potential to positively impact the nation’s and world’s ability to respond to the COVID-19 crisis. Areas of research that might be considered include, but are not limited to: artificial intelligence, digital health, diagnostics, distributed ledger, environmental technologies, medical devices, pharmaceutical technologies, disinfection and sterilization, and filtration and separations. Interested proposers are invited to submit to the NSF Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase I Program. 
https://www.nsf.gov/pubs/2020/nsf20065/nsf20065.jsp 
Deadline: rolling

Ecology and Evolution of Infectious Diseases (EEID)
The multi-agency Ecology and Evolution of Infectious Diseases program supports research on the ecological, evolutionary, and social drivers that influence the transmission dynamics of infectious diseases. The central theme of submitted projects must be the quantitative or computational understanding of pathogen transmission dynamics. The intent is discovery of principles of infectious disease transmission and testing mathematical or computational models that elucidate infectious disease systems. Projects should be broad, interdisciplinary efforts that go beyond the scope of typical studies. They should focus on the determinants and interactions of transmission among any host species, including but not limited to humans, non-human animals, and/or plants. This includes, for example, the spread of pathogens; the influence of environmental factors such as climate; the population dynamics and genetics of reservoir species or hosts; the feedback between ecological transmission and evolutionary dynamics; and the cultural, social, behavioral, and economic dimensions of pathogen transmission. Research may be on zoonotic, environmentally-borne, vector-borne, or enteric pathogens of either terrestrial or aquatic systems and organisms, including diseases of animals and plants, at any scale from specific pathogens to inclusive environmental systems. Proposals for research on disease systems of public health concern to developing countries are strongly encouraged, as are disease systems of concern in agricultural systems. Investigators are encouraged to develop the appropriate multidisciplinary team, including for example, anthropologists, modelers, ecologists, bioinformaticians, genomics researchers, social scientists, economists, oceanographers, mathematical scientists, epidemiologists, evolutionary biologists, entomologists, parasitologists, microbiologists, bacteriologists, virologists, pathologists or veterinarians, with the goal of integrating knowledge across disciplines to enhance our ability to predict and control infectious diseases.
https://www.nsf.gov/pubs/2020/nsf20585/nsf20585.htm?WT.mc_id=USNSF_25&WT.mc_ev=click
Deadline: November 18, 2020

DEPARTMENT OF DEFENSE

DOD Prototype Development to Combat Novel Coronavirus Disease COVID-19 
The Medical Technology Enterprise Consortium (MTEC) is excited to post this pre-announcement for a potential Request for Project Proposals (RPP) focused on the development of prototypes aimed to combat the coronavirus (COVID-19). In light of the magnitude and potential threat that the coronavirus (COVID-19) poses to the military’s health and readiness, the government seeks to rapidly accelerate the inquiry, testing, and fielding of new 21st century capabilities, employing novel technologies and approaches to the detection of exposure, prevention, containment and treatment of COVID-19 and future emerging threats. MTEC believes that an emphasis will be placed on technologies that can be deployed as soon as possible but no later than 31 December 2020. In support of this, MTEC has identified the following potential areas of interest:

  • Point-of-care diagnostic that provides rapid and accurate determination on exposure to COVID-19.
  • Prophylactic(s)/Therapeutic(s) that can prevent and/or treat in a rapid manner (few hours to 2 days) potentially in a non-hospital environment. Repurposing FDA-approved drugs/biologics for prevention/treatment of COVID-19 or testing of drugs/biologics that have already demonstrated safety in humans for the prevention/treatment of COVID-19 are preferred.
  • Disease predictive modeling that provides early warning through data capture from several different streams of data to include social media and artificial intelligence (AI) parameter decision tools that would provide actionable information to medical service providers and command structures.
  • Patient monitoring, tracking, and management system for in-home or non-hospital environment patient tele-health services to include interface into the Cerner electronic health record.
Although there is no specific funding commitment by the U.S. Government at this time, MTEC believes that there may be tens of millions of dollars available for combating COVID-19 programs with a likelihood of follow-on funding. The upcoming RPP(s) will be posted to the  MTEC website and a notice will be posted  here to notify interested parties. Contingent upon approval from the Government,  the upcoming RPP(s) is expected to be released within the next few weeks and will have an extremely short preparation period (approximately 14 days).  
https://beta.sam.gov/opp/53badf9fb02349e78839a541495efc6a/view 
Deadline: TBD (est. April 30, 2020) 

xTech COVID-19 Ventilator Challenge   
The Army’s xTech COVID-19 Ventilator Challenge seeks a low-cost, readily manufacturable emergency ventilator to quickly augment ventilator capacity during the COVID-19 pandemic. The technology solution must provide a rapid response breathing apparatus capable of short-term, rugged field operation. 
https://www.arl.army.mil/xtechsearch/ 
Deadline: Virtual pitches for selected companies will begin April 13  

OTHER FEDERAL OPPORTUNITIES

Fast-Track Program for COVID-19 Test Development and Distribution Innovative Technologies to Increase U.S. Capacity for COVID-19 Testing  
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is urgently soliciting proposals and can provide up to $500M across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx), is a fast-track technology development program that leverages the National Institutes of Health (NIH) Point-of-Care Technology Research Network (POCTRN). RADx will support novel solutions that build the U.S. capacity for SARS-CoV-2 testing up to 100-fold above what is achievable with standard approaches. RADx is structured to deliver innovative testing strategies to the public as soon as late summer 2020 and is an accelerated and comprehensive multi-pronged effort by NIH to make SARS-CoV-2 testing readily available to every American. NIBIB  is providing substantial support to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to  clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19. NIBIB will support the full range of product development including commercialization and product distribution.  
https://www.poctrn.org/radx  
Deadline: rolling

Innovative Commercial Products in Support of Coronavirus (COVID-19) Response Commercial Solutions Opening Pilot Program (CSOP)
The Department of Homeland Security (DHS) efforts in preparedness and readiness have facilitated a speedy, whole-of-government response in confronting COVID-19, keeping Americans safe, and helping detect and slow the spread of the virus. DHS is seeking innovative commercial products that are in support of the COVID-19 response or similar microbial threats. Considering the magnitude and potential threat that COVID-19 and similar microbial threats pose to our nation’s health, safety and security, the Government seeks to rapidly accelerate the testing and fielding of new capabilities, employing innovative commercial products to the detection of exposure, prevention, containment and treatment of COVID-19 and similar microbial threats. Such innovative commercial products would be in support of the mission of the DHS, including the assistance that the FEMA is providing, in coordination with the HHS, to state, local, tribal, territorial governments and other eligible entities under the Stafford Act.
Deadline: rolling  

NIST Manufacturing USA National Emergency Assistance Program 
NIST invites applications from the 2,000 current Manufacturing USA institutes, including small manufacturers, two-thirds of Fortune 50 U.S. manufacturers, and nearly every top ranked research and engineering university in the United States. NIST invites Manufacturing USA institutes to propose high-impact projects designed to respond to the COVID-19 pandemic. 
https://www.grants.gov/web/grants/search-grants.html?keywords=2020-NIST-MFGUSA-NEAP-01 
Deadline: rolling, through March 31, 2021  

Biomedical Advanced Research and Development Authority (BARDA) 
BARDA has updated its Broad Agency Announcements (BAAs) to focus exclusively on addressing the COVID-19 threat. BARDA, with a total budget of $512 Million, is seeking proposals through the following mechanisms:

Deadline: rolling 

Corona Watch 
The U.S. government is providing a portal for the 2019 novel coronavirus (COVID-19) medical countermeasures task force as a single point of entry for the submission of market research packages and meeting requests from interested stakeholders. The U.S. government, in response to the COVID-19 outbreak, seeks information from stakeholders on available medical countermeasures in development. We are particularly interested in products and technologies that have progressed into or beyond non-clinical trials, have established large-scale cGMP manufacturing capability, or utilize an approved platform. Information regarding diagnostics, therapeutics, vaccines, and other products or technologies relevant to addressing this outbreak are sought. At this time, we ask for a brief description of your product or technology, accompanied by a slide deck, manuscript, publications, or other non-confidential information of your choosing. Please note that while we will use any information you present as market research, submission is no guarantee of a meeting or funding and your submission will be shared across U.S. Government agencies involved in COVID-19 medical countermeasure research and development.  Only U.S. government officials are invited to join a CoronaWatch meeting, and are bound by law to maintain confidentiality of what is presented and discussed. Ideal technologies and products would (but are not required to) be: Relevant to the U.S. government COVID-19 medical countermeasure research and development efforts and/or Emerging Infectious Disease rapid response capabilities; Utilize an already-approved platform, have non-clinical data suggesting efficacy, and/or have significant manufacturing capability; Fully owned or licensed by your organization (you have full IP rights and/or freedom to operate) 
https://www.medicalcountermeasures.gov/Request-BARDA-TechWatch-Meeting/ 
Deadline: rolling

White House Announces the Launch of the COVID-19 High-Performance Computing Consortium
The COVID-19 HPC Consortium encompasses computing capabilities from some of the most powerful and advanced computers in the world. The consortium hopes to empower researchers around the world to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections.
https://www.xsede.org/covid19-hpc-consortium
Deadline: rolling

DOJ COVID 19 – Operational Challenges for Corrections
To effectively respond to operational challenges in a safe and secure manner, the entire field of corrections is continuously evolving and changing. This requires Corrections Executives to promote environments where continuous learning and professional development is embraced and encouraged throughout their organizations. With responsibility for leading complex systems, these executives are charged with managing human resources, and administering fiscal resources, all while supporting strong business practices and delivering positive results. Additionally, it is vitally important for Corrections Executives to stay current regarding critical issues facing the field, and the methods that they have employed for effectively addressing these challenges. For years, NIC has been committed to improving operational performance throughout corrections by providing information and data to support continuity of operations during crises.
https://www.grants.gov/web/grants/view-opportunity.html?oppId=328083
Deadline: August 27, 2020

NIST Manufacturing USA National Emergency Assistance Program
Collectively, Manufacturing USA institutes have over 2,000 member institutions including small manufacturers, two-thirds of Fortune 50 U.S. manufacturers, and nearly every top ranked research and engineering university in the United States. Its network of research and development institutes that engage with these industry-led institutions positions it well to distribute high-impact funding into existing efforts in the manufacturing sector to both stimulate the US economy and to support efforts to respond to the COVID-19 pandemic and other public health crises. Projects should focus on responding to the COVID-19 pandemic. Projects may include medical countermeasures; non-medical countermeasures; leveraging institute capabilities to strengthen state and community resilience; grants to companies and technical support to accelerate productions of critical materials, equipment, and supplies; creation of additional production facilities; technology roadmapping for pandemic response and recovery; reshoring the manufacture of critical conventional drugs and ensuring supply chain for critical materials related to pandemic response; or workforce development and training for a skilled advanced manufacturing workforce.
https://www.grants.gov/web/grants/view-opportunity.html?oppId=325811
Deadline: October 5, 2020

Private Foundations, Corporations and Other Agencies

COVID-19 Grants For History in the Public Interest 
The Albert Lepage Center for History in the Public Interest at Villanova University is pleased to announce a new funding opportunity to support historical projects related to the Covid-19 pandemic that advance the public interest. The Center will fund up to 10 projects that creatively engage with the broad range of questions, concerns, policies and practices raised by the study of how past pandemics have affected the course of history and how historical study can further public understanding of the current Covid-19 crisis. The Center is particularly interested in proposals that adopt a global approach and highlight issues of race, gender, power and structural inequality. We strongly encourage BIPOC and members of minority and underrepresented populations to apply.
Deadline: August 15, 2020

March of Dimes 2020 COVID-19 Fund
Currently, the health threats that moms and babies face include the COVID-19 viral pandemic where pregnant women and babies are at risk of infection and subsequent complications. The March of Dimes COVID-19 Fund was created to support the urgent need for COVID-19 specific research in maternal-child health, to help women preparing for childbirth, the families caring for a newborn, and healthcare providers during this time. We request applications that propose research in one of the following priority areas: Clinical characteristics: Includes studies that examine clinical and socio-demographic predictors of perinatal health outcomes and treatments associated with COVID-19 for the mom-baby dyad. Predictability may include, the role of the placenta in pregnancy outcomes in women who are infected and/or use of a ventilator in treating COVID-19; and  Maternal Immunity and Neonatal Health: Includes studies examining the role of antibody testing in birth planning and postpartum care, sustainability of antibodies/immunity in mom-baby dyad, the viability of passive immunity through breastmilk, and mom-to-baby contact.
Deadline: September 4, 2020

TD Ready Challenge
The TD Ready Challenge is an annual North American initiative, which supports organizations developing innovative solutions for a changing world. Recipients must be organizations that have impactful and measurable solutions focused on helping to open doors for a more inclusive and sustainable tomorrow. The 2020 TD Ready Challenge seeks to provide financial support to organizations that have designed innovative, scalable and/or replicable solutions to help address the pandemic-caused issues faced by communities that are experiencing disproportionate impacts of COVID-19 across North America. Solutions must address at least one (but can address more) of the four interconnected drivers of change of the TD Ready Commitment (Financial Security, Vibrant Planet, Connected Communities and Better Health). Applicants must deal directly with people and provide benefits to people and communities.
Deadline: August 13, 2020

Mind & Life Francisco J. Varela Research Grants
The Mind & Life Institute is seeking applications for the Mind & Life Francisco J. Varela Grants for Contemplative Research (Varela Grants). The Varela Grants are an integral component of Mind & Life's support of contemplative sciences--a growing field that aims to investigate contemplative practices through research in diverse disciplines ranging from basic and clinical sciences to social sciences and the humanities. This year, we especially encourage contemplative science proposals that demonstrate relevance to the current Covid-19 pandemic. For instance, a proposed study may focus on a specific population and how it is being affected by Covid-19. We also welcome methodological adaptations, such as for example conducting contemplative interventions and/or assessments online instead of in person, to allow for physical distancing. This program is intended as a career development grant, and is open to graduate students and post-doctoral fellows currently affiliated with a research institution, and junior faculty through their fifth year of university appointment.
Deadline: September 16, 2020

Aurora Prize for Awakening Humanity
As nominations open for the sixth annual Aurora Prize for Awakening Humanity, a special nomination form is introduced this year for the candidates whose response to the COVID-19 pandemic in any professional or personal capacity has been exemplary. The Aurora Prize is a global humanitarian award established to recognize modern day heroes and the exceptional impact their actions have made on preserving human life and advancing humanitarian causes in the face of adversity. On behalf of the survivors of the Armenian Genocide and in gratitude to their saviors, an Aurora Prize Laureate is honored each year with a cash award, which gives the Laureate a unique opportunity to continue the cycle of giving and support the organizations that have inspired humanitarian action. Nominations are open to the public and can be made for candidates who have put their life, health, freedom, reputation or livelihood at risk to preserve human life.
Deadline: October 31, 2020

Cisco Research Center (CRC) Pandemic/COVID19 Science, Technology and Social Impact
Pandemics have far reaching consequences that range from deaths to shutting down the economy as we have witnessed during the recent COVID19 crisis. Hence there is a need to be better prepared for such pandemics. We need to solve problems ranging from predictive analytics innovative devices for saving lives to technology for devising voting machines. The social and economic impact for the above areas is huge and some of the work can be transformative and save lives.  Areas of interest to us include, but are not limited to:  Mathematical models for spread and the impact of pandemics; Scalable simulation techniques for pandemics (e.g. with multi agents); Biomedical/Nano sensor devices for detecting symptoms and agents; Algorithms for rapid exploration of the drug screening and discovery workflows (e.g. use reinforcement learning); Advanced computational biology techniques for sequencing, detecting viral evolution (e.g. in COVID-19); Algorithms and systems for contact tracing (with privacy preserving).; Algorithms and recommendation systems for curating media and news; Collaboration techniques for more effective health, and efficiency during pandemics; Improved identity and security techniques; Distributed Ledgers, their applications and their governance for and during pandemics; Pandemic data science - understanding the patterns and the impact of a pandemic like COVID-10; and Creation of curated data sets.  We are interested in both the science and technology aspects of these problem sets, and, particularly, in the intersections between them. By cultivating stronger partnerships between scientists, technologists, and the broader community; we hope to achieve an acceleration of scientific research and conservation outcomes as we push the boundaries of our technologies and architectures to support larger-scale studies, more sophisticated analyses, and translation of learnings across multiple domain areas.
Deadline: Applications will be accepted on a rolling basis

Coronavirus Urgent Response Initiative 
The Draper Richards Kaplan Foundation invites applications for funding under its COVID-19 urgent response initiative. This supports innovative solutions that address time-critical social problems caused by the COVID-19pandemic. Solutions should be fully scalable, lead to lasting change and be deployable within 30 days.

COVID-19 Collective Fund for Trans Communities
Borealis Philanthropy's Fund for Trans Generations, Destination Tomorrow's TRANScend Community Impact Fund, and Third Wave Fund have launched the COVID-19 Collective Fund for Trans Communities to get financial resourcesto trans-led organizations and transgender, gender nonconforming, and non-binary communities who are organizing in response to the COVID-19 crisis. Priority will be given to trans-led organizations with a racial justice focus. We encourage requests by Black, Indigenous, and other people of color (BIPOC). Some examples of activities that may be supported by this collective's grantmaking include, but are not limited to: Mutual aid and care support networks; Healing and virtual wellness spaces; Online/virtual programming needs; Living stipends for members and/or staff; Survival needs i.e. food, rent support, shelter, utilities; and Organizing and advocacy. 
https://borealisphilanthropy.org/grantmaking/fund-for-trans-generations/covid-19-collective-fund-for-trans-communities/
Deadline: rolling

Direct COVID-19 Response - Charitable Grant 
The effect of the COVID-19 pandemic on the impact sector has reached natural disaster proportions in its scope and scale, which means that the global need for our 'emergency' capital vastly outstrips our available resources. Given this reality, we have decided to use our limited resources to best serve the sector under the following circumstances: Charitable Grants will only be offered to organizations responding directly to COVID-19. This grant is for organizations engaging in direct COVID-19 response. We will prioritize organizations and activities that have a clear and direct role in `flattening the curve' and thus limiting, shortening, or minimizing the economic and social, as well as health effects of the pandemic. Slowing and stopping the spread of COVID-19 is directly linked to reducing and limiting the economic and social hardship our communities are experiencing.
https://openroadalliance.org/covid-19/
Deadline: rolling

Mozilla COVID-19 Solutions Fund 
The Mozilla Open Source Support (MOSS) Program, created in 2015, broadens access, increases security, and empowers users by providing catalytic funding to open source technologists. We have already seen inspiring examples of open source technology being used to increase the capacity of the world's healthcare systems to cope with this crisis. As part of the COVID-19 Solutions Fund, we will accept applications that are hardware (e.g., an open source ventilator), software (e.g., a platform that connects hospitals with people who have 3D printers who can print parts for that open source ventilator), as well as software that solves for secondary effects of COVID-19 (e.g., a browser plugin that combats COVID related misinformation)
Deadline: rolling            

Novartis US COVID-19 Community Response Fund
In response to the COVID-19 pandemic, the Novartis US Foundation has established the US COVID-19 Community Response Fund to support local initiatives and communities in the US impacted by the outbreak. Programs must support one or more of the three stated objectives: (1) strengthening local and national healthcare infrastructure to meet increased demand and protect frontline health workers, (2) establishing digital platforms for COVID-19 related data collection, remote delivery of healthcare and effective dissemination of important public health information, and (3) creating or enhancing new community health programs specific to the pandemic response.
https://www.novartis.us/news/novartis-us-covid-19-initiatives
Deadline: rolling

Williams Foundation 
The  Williams Foundation has pledged $1 million to make grants to community organizations that focus primarily on emergency response, food insecurity, health and human services, and distance-learning solutions for public schools throughout the coronavirus outbreak. Eligible recipients include nonprofit groups, first responders, and public schools in the 24 states where the natural-gas company does business.
https://investor.williams.com/press-releases/press-release-details/2020/Williams-Foundation-Pledges-1-Million-for-Coronavirus-Response-and-Community-Recovery/default.aspx
Deadline: rolling

Hayek Fund for Scholars
The Hayek Fund for Scholars supports students and faculty who are researching and teaching the ideas of liberty within the social sciences and humanities by funding a wide range of research- and career-advancing activities. From paying for PhD application fees to conference presentation travel to the purchase of crucial data sets, this unique fund helps cover an extensive array of expenses. The Hayek Fund helps pay for activities including (but not limited to):

  • Expenses related to remote/online teaching and scholarly collaboration incurred as a consequence of the COVID-19 pandemic
  • Purchase of books or online resources to support teaching and research
  • Travel for paper presentations or job interviews at academic conferences
  • Submission fees for unpublished manuscripts and academic journal articles
  • Travel for archival research*
  • Purchase of data sets
  • Participation in seminars or peer reviews*
  • Collaborative research projects or the hiring of a research assistant
  • Facilitation of thought-provoking reading groups and book clubs with students*
  • Reimbursement of application fees for PhD programs
*Note restrictions.
https://theihs.org/funding/hayekfund/
Deadline: rolling

Amazon Web Services Diagnostic Development Initiative (DDI)
The AWS Diagnostic Development Initiative (DDI) provides support for innovation in rapid and accurate patient testing for 2019 novel coronavirus (COVID-19), and other diagnostic solutions to mitigate future outbreaks. Although vaccine and treatment development research is generally funded by private foundations and government agencies, fast and reliable diagnostic techniques are slow to be developed. Accurate testing and diagnosis at point-of-care or regional locations for patients with COVID-19 is critical to early intervention and treatment. AWS is offering technical support and providing AWS promotional credits to support the use of AWS services to advance diagnostic research for selected institutions and companies.
https://aws.amazon.com/government-education/nonprofits/disaster-response/diagnostic-dev-initiative/
Deadline: rolling

Wellcome Trust - The COVID-19 Therapeutics Accelerator
Wellcome joins the Bill & Melinda Gates Foundation and Mastercard in launching a new initiative to speed the development of and access to therapies for COVID-19. The COVID-19 Therapeutics Accelerator will coordinate research efforts and remove barriers to drug development. Currently there are no approved treatments for COVID-19. This new initiative aims to fill that gap by accelerating and evaluating new and repurposed drugs and biologics to treat patients with COVID-19 in the immediate term, and other viral pathogens in the longer-term. The partners are committed to equal access, ensuring treatments are accessible and affordable in low-resource settings. The COVID-19 Therapeutics Accelerator will work closely with the World Health Organization, government and private sector funders, and global regulatory and policy-setting institutions. It will have an end-to-end focus - from drug pipeline development through to manufacturing and scale-up - and will provide fast and flexible funding at key stages of the process.
https://wellcome.ac.uk/news/wellcome-pledges-50-million-new-initiative-speed-development-covid-19-treatments
Deadline: rolling

Equal Sound Corona Relief Fund
The Equal Sound Corona Relief Fund was set up on short notice to provide direct financial assistance to musicians who have lost work as a result of Corona-related event cancellations.
https://equalsound.org/project/corona-relief-fund/
Deadline: rolling

Robert Wood Johnson Foundation Pioneering Ideas: Exploring the Future to Build a Culture of Health
Pioneering Ideas: Exploring the Future to Build a Culture of Health seeks proposals that are primed to influence health equity in the future. We are interested in ideas that address any of these four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work. Additionally, we welcome ideas that might fall outside of these four focus areas, but which offer unique approaches to advancing health equity and our progress toward a Culture of Health. We want to hear from scientists, anthropologists, artists, urban planners, community leaders—anyone, anywhere who has a new or unconventional idea that could alter the trajectory of health, and improve health equity and well-being for generations to come. The changes we seek require diverse perspectives and cannot be accomplished by any one person, organization or sector. While this call for proposals is focused on broader and longer-term societal trends and shifts that were evolving prior to the COVID-19 outbreak, we recognize the unique circumstances and learning created by the COVID-19 pandemic may inform your response. It is at your discretion whether you propose a project related to the pandemic directly or indirectly.
Deadline: Proposals will be accepted throughout the year on a rolling admission

PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Dissemination and Implementation Awards
PCORI seeks investigator-initiated proposals to address the COVID-19 public health crisis with enhancements to currently funded PCORI Dissemination and Implementation awards. Only PCORI-funded investigators or project leads with active Dissemination and Implementation Award contracts are eligible to submit a proposal in response to this announcement. PCORI has a strong interest in addressing dilemmas facing patients, clinicians, health systems, and other stakeholders and entities battling the novel coronavirus pandemic in the United States. We are interested in supporting work that can be initiated quickly to mitigate the outcome of the current pandemic by using existing teams with ongoing working relationships with PCORI. Taking advantage of natural experiments in health system, state, and provider responses is encouraged. Proposed enhancements should boost the existing Dissemination and Implementation project’s overall impact and do so by responding to needs evolving or emerging in the context of the COVID-19 pandemic. Such needs include, but are not limited to, challenges to mental health and well-being of healthcare workers, social support for vulnerable populations experiencing isolation or restrictions in mobility, prevention and treatment of COVID-19, and health system adaptations to compensate for shortages of personnel and supplies.
https://www.pcori.org/funding-opportunities/announcement/covid-19-related-enhancements-dissemination-implementation-awards
Deadline: rolling

PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Engagement Awards 
PCORI has a strong interest in generating timely findings to provide answers to dilemmas facing patients, clinicians, health systems, and other stakeholders and entities battling the novel coronavirus pandemic in the United States. Through this announcement, we are interested in supporting Enhancements to existing Engagement Awards that can be initiated sufficiently quickly to influence the outcome of the current pandemic by using existing teams that are currently funded by PCORI. They should have some relationship to the original award. Enhancements may include modest additions to existing aims, or an adjunct project that has some relationship to the original award, including a new aim (or aims) designed to produce useful knowledge or research support related to COVID-19 and the original award. Simultaneous adaptation of original aims to account for COVID-19 may also be proposed. Taking advantage of natural experiments in health system, state, and provider responses is encouraged.  Only PCORI-funded project leads with active Engagement Award contracts are eligible to submit a proposal in response to this funding announcement. 
https://www.pcori.org/funding-opportunities/announcement/covid-19-related-enhancements-engagement-awards 
Deadline: rolling

Artist Relief
Artist Relief is an initiative organized by the Academy of American Poets, Artadia, Creative Capital, Foundation for Contemporary Arts, MAP Fund, National YoungArts Foundation, and United States Artists—all small to mid-sized national arts grantmakers—that have come together in this unprecedented moment guided by the understanding that the wellbeing of artists has financial, professional, social, and mental dimensions, and should be fostered with a holistic framework of support. As such, Artist Relief will distribute $5,000 grants to artists facing dire financial emergencies due to COVID-19.
https://www.artistrelief.org/about
Deadline: Applications will be accepted until August 20, 2020 in five grant cycles

Arts Administrators of Color: Arts Leaders of Color Emergency Fund
Arts Administrators of Color has created the Arts Leaders of Color Emergency Fund, which supports BIPOC (Black, Indigenous, and People of Color) artists and arts administrators impacted by COVID-19 through one-time microgrants of $200.
https://aacnetwork.org/
Deadline: rolling

Merck KGaA Research Grant for Pandemic Preparedness
Research grants for technological solutions towards pandemic outbreak preparedness or solutions that could help fighting emerging viral infections. Proposals will be considered that leverage technological solutions to be more prepared for pandemic outbreaks or solutions that could help to fight emerging viral infections. Pre-outbreak R&D Preparedness for pandemic disease: Assessing the priority of pathogens and diseases with epidemic threat; Platform technologies to accelerate the development of vaccines, drugs, diagnostics, vector control tools and delivery systems needed to control emerging health threats; and Innovative technologies for better personal protection equipment for infection control. Response during outbreak: Novel health technologies (e.g. AI, bioelectronics, diagnostics) for early screening of potential infected patients and treatment facilitation; and Fast-track identifying, testing and production of effective drugs and vaccines during outbreak.
https://www.emdgroup.com/en/research/open-innovation/2020-research-grants/research-grant-pandemic-preparedness.html.html
Deadline: rolling

Notice of Intent: New Supplemental Funding Opportunity Announcement to Support Existing Studies Evaluating the Implementation and Impact of System Alignment Mechanisms Within the Context of COVID-19
Systems for Action intends to publish a new funding opportunity announcement to extend existing studies evaluating the impact of systems alignment mechanisms on addressing health and social disruption related to the COVID-19 Pandemic. This Notice is being provided to allow potential applicants sufficient time to develop responsive applications. Applicants responding to this CFP may apply for awards of 12 months or 24 months in duration and up to $100,000 per year in total costs to support supplemental studies that evaluate the implementation and impact of a system alignment mechanism in the context of the COVID-19 pandemic . These awards are designed to serve as supplements to active or recently completed studies of the system alignment mechanism, allowing the applicant to rigorously evaluate how the system alignment mechanism performs in helping people navigate economic, social and health disruptions associated with the COVID-19 pandemic. In evaluating impact, studies should focus on health, social and/or economic outcomes of interest, and on population groups disproportionately affected by COVID-19 and/or its economic and social disruptions. The abbreviated time frame and limited funding level place emphasis on studies that can be implemented expeditiously by using previously collected data and existing research procedures established through an active or recently completed study.
https://mcusercontent.com/9a7842922937d30199fc610b1/files/7bdf1bf1-8404-4ffe-9583-0d663908c42f/RWJF_S4A_Notice_of_Intent.pdf
Deadline: August 5, 2020

UN Trust Fund for Human Security
Established in 1999 by the Executive Office of the Secretary-General (EOSG), the UNTFHS has been a pioneering financing mechanism, advancing integrated programmes by the UN system and partners that are comprehensive, people-centred, context-specific and preventive. Today, these principles of human security are reflected in the reform of the UN system as well as major global agendas. As such, the UNTFHS is a valuable mechanism for catalysing concrete action to strengthen the UN's ability to better deliver for people facing complex and interconnected challenges, particularly at the local level. The UNTFHS supports two distinct types of programmes: (1) those that mainstream and advance the operational impact of the human security approach and (2) those that extend the global awareness of the human security approach and its usage. Against the backdrop of the COVID-19 pandemic sweeping the globe and causing an unprecedented threat to people's survival, livelihoods and dignity, there is a resurgence of interest within and beyond the United Nations in human security. As such, the UNTFHS will focus the 2020 Call for Proposals on outreach and advocacy programmes to extend awareness of the human security approach and its usage at all levels (window 2). The outreach and advocacy programmes should focus on applying human security to develop innovative strategies to address compound challenges, such as: Responding to the multidimensional impacts of health crises, including COVID-19; Humanitarian-development-peace nexus issues such as the intersection of climate change, displacement and the SDGs; Resolution of cross-border challenges through regional frameworks; and Establishment of a global awareness raising campaign on human security. These programmes should deepen knowledge on how the application of human security can help address compound challenges that cut across mandates, disciplines and institutions. Programmes can incorporate assessments and practice- or policy-oriented research on human security on the condition that they lead to concrete proposals on new tools, strategies or practical solutions based on the human security approach that may be adopted by the UN system and Member States to prevent, overcome and build back better from complex crises.
https://www.un.org/humansecurity/trustfund/faqs-2/
Deadline: September 3, 2020

Russell Sage Foundation (RSF) COVID-19 Research
RSF will be funding research on the COVID-19 pandemic and the resulting recession in the U.S. Specifically, research that assesses the social, political, economic, and psychological causes and consequences of the pandemic, especially its effects on marginalized individuals and groups and on trust in government and other institutions. Their priorities do not include analyses of health outcomes or health behavior.
https://www.russellsage.org/how-to-apply
Deadline: August 5, 2020

International Research Network for the Study of Science and Belief in Society Seed Funding and Small Research Grants
Please note that this grant scheme has been revised from its original format in response to the COVID-19 pandemic. It is open to research exploring any aspect of the study of religion and science in society. This includes, but is not limited to, research in relation to the COVID-19 pandemic. ? The ‘Small Research Grant’ Fund has been designed to support academics just starting out in their careers in the field or seeking to establish themselves further by conducting socially relevant research in this field. There is currently a significant gap in research into the social and cultural dimensions of the relationship between science and religion in diverse global contexts. The lack of highquality research on contemporary religious, spiritual or non-religious publics' views on science and religion, and how these views relate to individuals' day-to-day lived experience, has led to the perpetuation of a range of misconceptions and/or polarising narratives. This Seed Funding and Small Research Grant scheme seeks to promote the growth of the social study of science and religion globally, by supporting the ongoing development of an international network of active academic researchers. This will be achieved through the provision of small grants that stimulate new avenues of individual or collaborative research internationally.
https://scienceandbeliefinsociety.org/grants/how-to-apply/
Deadline: Rolling, through October 1, 2020

COVID-19 RFP Program: COMMIT™
In an effort to further address the unmet medical need in COVID-19, Gilead Medical Affairs is launching the COMMIT program. (COvid-19 unMet MedIcal needs and associated research exTension). Gilead will consider support for research proposals that meet one of the following criteria: 1. Expand data on clinical course and outcome in vulnerable populations: Immune suppressed, specifically- HIV, cancer chronic inflammatory conditions (i.e., RA or IBD), and chronic liver disease, pre-existing pulmonary disease; Residents of long-term care facilities/nursing homes, and older adults; and At risk for healthcare disparities (e.g. Black/African American, socio-economic class). 2. Long-term sequelae (i.e., pulmonary fibrosis, neurologic, cardiac, quality of life). 3. Real world safety and effectiveness of remdesivir used alone or with other agents (JAK inhibitors, IL-6 inhibitors, convalescent plasma and ACE inhibitors and ARBs): Viral kinetics and clinical outcomes; Based on duration of treatment (e.g., 5 vs 10 days, shorter courses); Use in early (non-severe) disease; Course completion in alternative (non-inpatient setting) or alternative treatment pathways.
https://www.gilead.com/science-and-medicine/research/investigator-sponsored-research/covid19-commit-rfp
Deadline: LOI is due by August 8, 2020.

Fast Funding for COVID-19 Science
Science funding mechanisms are too slow in normal times and may be much too slow during the COVID-19 pandemic. Fast Grants are an effort to correct this. If you are a scientist at an academic institution currently working on a COVID-19 related project and in need of funding, we invite you to apply for a Fast Grant. Fast Grants are $10k to $500k and decisions are made in under 14 days. If we approve the grant, you'll receive payment as quickly as your university can receive it. You must be: A PI at an academic institution; Already working on a project that could help with the COVID-19 pandemic within the next six months; and In need of additional funding to complete the project.
https://fastgrants.org/
Deadline: Applications are accepted until funds run out.

Teacher Creativity Fellowship Program
Lilly Endowment is pleased to announce the 34th round of its Teacher Creativity Fellowship Program (TCFP). The Teacher Creativity fellowship is one of the Endowment's longest standing programs and began as a way to help Indiana elementary and secondary educators renew their commitment to teaching. We are aware that educators are facing mounting and evolving challenges related to the COVID-19 pandemic. Especially during this difficult time, the TCFP renewal program plans to support educators through new experiences, exploration and reflection. The Endowment anticipates that educators will discover renewed energy in their careers, innovative approaches to teaching and educational leadership, and thoughtful ways to encourage students' creative thinking.
https://lillyendowment.org/for-grantseekers/renewal-programs/teacher-creativity/
Deadline: November 2, 2020.

Additional Resources and Databases

SDSN’s Epidemiology and Economics of Coronavirus Webinar
The Sustainable Development Solutions Network hosted a webinar to examine the implications of COVID-19 for public health and the SDGs, as well as to make recommendations on science-based responses. A recording of the video will be available on the SDSN YouTube channel.
https://www.unsdsn.org/e-conference-the-epidemiology-and-economics-of-coronavirus

NIH/NCBI/NLM’s LitCovid Literature Hub
LitCovid is a curated literature hub for tracking up-to-date scientific information about the Coronavirus. It is the most comprehensive resource on the subject, providing central access to a growing number of relevant articles in PubMed. The articles are updated daily and are further categorized by different research topics and geographic locations for improved access.
https://www.ncbi.nlm.nih.gov/research/coronavirus/